ONL Therapeutics' Series A Round

ONL Therapeutics raised a round of funding on May 17, 2017.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly gro…

Articles about ONL Therapeutics' Series A Round: